Viatris (VTRS)
(Delayed Data from NSDQ)
$11.35 USD
-0.21 (-1.82%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $11.34 -0.01 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
Price, Consensus and EPS Surprise
VTRS 11.35 -0.21(-1.82%)
Will VTRS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VTRS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VTRS
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
VTRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Seeking Clues to Viatris (VTRS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?
Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline
Other News for VTRS
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Viatris Announces Second Quarter 2024 Dividend
Viatris declares $0.12 dividend
Earnings week ahead: Disney, Duke Energy, Palantir, Shopify, Uber and more
Chris Davis' Davis Opportunity Fund 2024 Semi-Annual Review: Looking Back